Multiple-Dose Up-Titration Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Selexipag, an Orally Available Selective Prostacyclin Receptor Agonist, in Healthy Subjects-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Multiple-Dose Up-Titration Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Selexipag, an Orally Available Selective Prostacyclin Receptor Agonist, in Healthy Subjects

Published:2014 Issue:3-4 Volume:94 Page:148-156
ISSN:1423-0313
Container-title:Pharmacology
language:en
Short-container-title:Pharmacology

Author:

Bruderer Shirin,Hurst Noémie,Kaufmann Priska,Dingemanse Jasper

Publisher

S. Karger AG

Subject

Pharmacology,General Medicine

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A real-world analysis of safety profile of selexipag by using FDA adverse Event Reporting System (FAERS);Expert Opinion on Drug Safety;2023-11-30

2. Assessment of environmental impact of a novel stability-indicating RP-HPLC method and reported methods for the determination of selexipag in bulk and dosage form: A comparative study using different greenness assessment tools;Microchemical Journal;2023-02

3. Clinical efficacy and safety of selexipag in children and young adults with idiopathic and heritable pulmonary arterial hypertension;Cardiology in the Young;2022-04-06

4. Antiplatelet effects of prostacyclin analogues: Which one to choose in case of thrombosis or bleeding?;Cardiology Journal;2021-12-31

5. Endothelin receptor antagonists for pulmonary arterial hypertension;Cochrane Database of Systematic Reviews;2021-03-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP